Elara Capital observes that Aurobindo Pharma has 14 biosimilars in the pipeline. The company has also filed 3 biosimilars for ...

Aurobindo Pharma USA will acquire Lannett from Lannett Seller Holdco for $250 million on a cash-free, debt-free basis.

Motilal Oswal is bullish on Aurobindo Pharma has recommended buy rating on the stock with a target price of Rs 1300 in its ...

Recent hiccups related to manufacturing plant issues and tariff uncertainties have led to volatility in earnings and, ...

Prabhudas Lilladher is bullish on Aurobindo Pharma has recommended buy rating on the stock with a target price of Rs 1300 in ...

Aurobindo Pharma's consolidated net profit fell by 10.2% to ₹824 crore in Q1, despite a 4% increase in revenue driven by European and growth market sales.

Following US President Trump's tariff announcement, Indian pharmaceutical and textile companies experienced significant stock ...

In a market overshadowed by US tariff threats and a tumbling rupee, cautious trading is essential. This article outlines the ...

Brokerage have shared views on multiple stocks today (August 6) post quarterly results. The top stocks that are on the radar ...

Follow the Q1 FY26 results insights of over 100+ companies like Bharti Airtel, Adani Ports, Britannia, Exide, Eveready, ...

The S&P BSE Sensex was down 65.70 points to 80.644.34 at 9:40 am, while the NSE Nifty50 fell 28.40 points to trade at 24,620.

The recovery made by the Nifty 50 index on Monday, marking a strong start to the week after five weeks of selling, will be ...